News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
861,515 Results
Type
Article (87471)
Company Profile (806)
Press Release (773216)
Multimedia
Podcasts (175)
Webinars (28)
Section
Business (233068)
Career Advice (4140)
Deals (39800)
Drug Delivery (138)
Drug Development (91261)
Employer Resources (203)
FDA (18287)
Job Trends (17403)
News (397428)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (126)
Alliances (56980)
ALS (147)
Alzheimer's disease (1684)
Antibody-drug conjugate (ADC) (256)
Approvals (18318)
Artificial intelligence (499)
Autoimmune disease (85)
Automation (27)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (163)
Biotechnology (485)
Bladder cancer (135)
Brain cancer (53)
Breast cancer (514)
Cancer (4037)
Cardiovascular disease (346)
Career advice (3560)
Career pathing (38)
CAR-T (250)
CDC (57)
Cell therapy (693)
Cervical cancer (33)
Clinical research (75620)
Collaboration (1408)
Company closure (4)
Compensation (942)
Complete response letters (60)
COVID-19 (2960)
CRISPR (81)
C-suite (600)
Cystic fibrosis (139)
Data (4630)
Decentralized trials (2)
Denatured (63)
Depression (112)
Diabetes (456)
Diagnostics (7095)
Digital health (37)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (238)
Drug pricing (191)
Drug shortages (36)
Duchenne muscular dystrophy (204)
Earnings (98901)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (133124)
Executive appointments (994)
FDA (20791)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1271)
Gene editing (173)
Generative AI (50)
Gene therapy (550)
GLP-1 (1024)
Government (5386)
Grass and pollen (7)
Guidances (351)
Healthcare (20938)
HIV (48)
Huntington's disease (40)
IgA nephropathy (64)
Immunology and inflammation (245)
Immuno-oncology (21)
Indications (53)
Infectious disease (3208)
Inflammatory bowel disease (188)
Inflation Reduction Act (16)
Influenza (101)
Intellectual property (192)
Interviews (816)
IPO (17928)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (17)
Labor market (80)
Layoffs (641)
Leadership (36)
Legal (10148)
Liver cancer (92)
Longevity (13)
Lung cancer (581)
Lymphoma (268)
Machine learning (31)
Management (66)
Manufacturing (647)
MASH (141)
Medical device (14884)
Medtech (14909)
Mergers & acquisitions (22760)
Metabolic disorders (1165)
Multiple sclerosis (138)
NASH (23)
Neurodegenerative disease (233)
Neuropsychiatric disorders (62)
Neuroscience (2734)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (59)
Obesity (563)
Opinion (314)
Ovarian cancer (136)
Pain (168)
Pancreatic cancer (173)
Parkinson's disease (243)
Partnered (30)
Patents (423)
Patient recruitment (323)
Peanut (57)
People (66295)
Pharmaceutical (145)
Pharmacy benefit managers (27)
Phase I (23326)
Phase II (32825)
Phase III (24735)
Pipeline (2756)
Policy (295)
Postmarket research (3554)
Preclinical (10523)
Press Release (72)
Prostate cancer (202)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (684)
Real estate (7422)
Recruiting (79)
Regulatory (28053)
Reports (65)
Research institute (2692)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (137)
Series A (211)
Series B (158)
Service/supplier (30)
Sickle cell disease (81)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (41)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (96)
The Weekly (110)
Vaccines (1055)
Venture capital (67)
Weight loss (398)
Women's health (59)
Worklife (21)
Date
Today (45)
Last 7 days (706)
Last 30 days (2589)
Last 365 days (33465)
2025 (27051)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (80)
Alaska (7)
Arizona (304)
Arkansas (14)
Asia (51010)
Australia (8964)
California (9582)
Canada (2888)
China (918)
Colorado (405)
Connecticut (428)
Delaware (273)
Europe (117191)
Florida (1409)
Georgia (317)
Hawaii (3)
Idaho (67)
Illinois (817)
India (52)
Indiana (466)
Iowa (20)
Japan (329)
Kansas (125)
Kentucky (38)
Louisiana (21)
Maine (78)
Maryland (1289)
Massachusetts (7185)
Michigan (315)
Minnesota (566)
Mississippi (4)
Missouri (122)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (79)
New Jersey (2657)
New Mexico (32)
New York (2600)
North Carolina (1421)
North Dakota (10)
Northern California (4359)
Ohio (300)
Oklahoma (22)
Oregon (50)
Pennsylvania (1989)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (50)
South Dakota (1)
Southern California (3656)
Tennessee (150)
Texas (1505)
United States (35339)
Utah (284)
Virginia (250)
Washington D.C. (84)
Washington State (824)
West Virginia (4)
Wisconsin (98)
Wyoming (1)
There are 861,515 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bayer’s Lynkuet® (elinzanetant), the First and Only Neurokinin 1 and Neurokinin 3 Receptor Antagonist, Receives FDA Approval for Moderate to Severe Hot Flashes Due to Menopause
October 27, 2025
·
9 min read
Press Releases
BridgeBio to Report Phase 3 Results for Small Molecule BBP-418 in LGMD2I/R9 FORTIFY Study, along with Third Quarter 2025 Financial Results Next Week
October 27, 2025
·
1 min read
Press Releases
Arvinas Presents Preclinical Data for ARV-806 Demonstrating Robust and Differentiated Activity in Models of KRAS G12D-mutated Cancer at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 27, 2025
·
7 min read
Press Releases
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 24, 2025
October 27, 2025
·
3 min read
Press Releases
Enzon and Viskase Announce Amendment to Merger Agreement
October 27, 2025
·
10 min read
Press Releases
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - October 24, 2025
October 27, 2025
·
1 min read
Press Releases
Published in The Lancet: Nipocalimab significantly decreased Sjögren’s disease (SjD) activity and severity through substantial reduction in Sjögren’s-related autoantibodies
October 27, 2025
·
15 min read
Press Releases
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium
October 27, 2025
·
5 min read
Press Releases
Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement
October 27, 2025
·
2 min read
Press Releases
Phathom Pharmaceuticals Announces Publication of Data from Phase 3 pHalcon-NERD-301 Study Showing VOQUEZNA® (vonoprazan) Improved Nocturnal GERD Symptoms in Patients with Non-Erosive Reflux Disease
October 27, 2025
·
13 min read
1 of 86,152
Next
